Elasmogen: Elasmogen Announces Grants Of 2 New VNAR and soloMER Patent Families
New grants across multiple territories cover the use of humanised or de-immunised VNARs for therapeutic applications ABERDEEN, Scotland, Dec. 9, 2020 /PRNewswire/ -- Elasmogen Ltd, the biopharmace...
Read full article »
Elasmogen is a Scotland-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer and inflammatory diseases.
Read more